{
    "nctId": "NCT02203565",
    "briefTitle": "Dakin's Solution in Preventing Radiation Dermatitis in Patients With Breast Cancer Undergoing Radiation Therapy",
    "officialTitle": "Pilot Study to Investigate the Impact of Hypochlorite in the Prevention of Radiation Dermatitis",
    "overallStatus": "COMPLETED",
    "conditions": "Breast Cancer, Skin Reactions Secondary to Radiation Therapy",
    "studyType": "INTERVENTIONAL",
    "phase": "PHASE2",
    "allocation": "NA",
    "primaryPurpose": "SUPPORTIVE_CARE",
    "enrollmentCount": 20,
    "primaryOutcomeMeasure": "Percent of Women Who Develop Grade 3 or 4 Radiation Dermatitis (as Defined by the Stanford Radiation Dermatitis Scoring System) During a Course of Radiation Therapy",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Women with breast cancer who plan to undergo radiation therapy to the breast or chest wall\n* Ability to understand and the willingness to sign a written informed consent document\n\nExclusion Criteria:\n\n* Women with scleroderma or discoid lupus\n* Women with inflammatory breast cancer as evidenced by clinical assessment\n* Women with breast cancer involving the skin\n* Women who have undergone prior radiotherapy to the chest wall and/or breast",
    "sex": "FEMALE",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}